Literature DB >> 3137077

Multiple associated endocrine abnormalities in a patient with pseudohypoparathyroidism type 1a.

M Shima1, O Nose, K Shimizu, Y Seino, H Yabuuchi, T Saito.   

Abstract

A girl with type 1a pseudohypoparathyroidism (PHP) presented several hormonal abnormalities. Although she had eluded neonatal thyroid screening, she was diagnosed as having hypothyroidism at the age of 5 months. Thereafter, a diagnosis of PHP was made on the basis of skeletal features of Albright osteodystrophy and lack of both cyclic adenosine monophosphate (c-AMP) and phosphaturic responses after parathyroid hormone (PTH) infusion. The basal levels of luteinizing hormone (LH) and follicle stimulating hormone (FSH) were higher than normal and showed exaggerated responses to luteinizing hormone-releasing hormone (LH-RH). There was no growth hormone (GH) response to arginine infusion, and the prolactin (PRL) response after thyrotropin-releasing hormone (TRH) infusion, was also impaired. The stimulating guanine nucleotide-binding protein (Ns) activity of the erythrocytes was reduced to 66.9%. The skeletal age was not delayed at the age of 5 months in spite of the hypothyroid state, and it advanced following thyroxine and vitamin D treatments.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3137077     DOI: 10.1007/bf00441985

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  12 in total

1.  Partial gonadotrophin-resistance in pseudohypoparathyroidism.

Authors:  J I Wolfsdorf; R L Rosenfield; V S Fang; R Kobayashi; A K Razdan; M H Kim
Journal:  Acta Endocrinol (Copenh)       Date:  1978-06

2.  Pseudohypoparathyroidism type 1a presenting as congenital hypothyroidism.

Authors:  Y Weisman; A Golander; Z Spirer; Z Farfel
Journal:  J Pediatr       Date:  1985-09       Impact factor: 4.406

3.  Infantile hypothyroidism in two sibs: an unusual presentation of pseudohypoparathyroidism type Ia.

Authors:  M A Levine; T S Jap; W Hung
Journal:  J Pediatr       Date:  1985-12       Impact factor: 4.406

4.  Resistance to multiple hormones in patients with pseudohypoparathyroidism. Association with deficient activity of guanine nucleotide regulatory protein.

Authors:  M A Levine; R W Downs; A M Moses; N A Breslau; S J Marx; R D Lasker; R E Rizzoli; G D Aurbach; A M Spiegel
Journal:  Am J Med       Date:  1983-04       Impact factor: 4.965

5.  Altered dopaminergic modulation of prolactin and aldosterone secretion in pseudohypoparathyroidism.

Authors:  J R Sowers; A S Brickman; N Asp; M L Tuck; K Jasberg; S Magnone
Journal:  J Clin Endocrinol Metab       Date:  1981-05       Impact factor: 5.958

6.  Prolactin deficiency in pseudohypoparathyroidism.

Authors:  H E Carlson; A S Brickman; G F Bottazzo
Journal:  N Engl J Med       Date:  1977-01-20       Impact factor: 91.245

7.  Defect of receptor-cyclase coupling protein in psudohypoparathyroidism.

Authors:  Z Farfel; A S Brickman; H R Kaslow; V M Brothers; H R Bourne
Journal:  N Engl J Med       Date:  1980-07-31       Impact factor: 91.245

8.  Pseudohypoparathyroidism associated with hypercalcitoninaemia.

Authors:  G Wägar; J Lehtivuori; I Salvén; R Backman; A Sivula
Journal:  Acta Endocrinol (Copenh)       Date:  1980-01

9.  Multiple abnormalities of anterior pituitary hormone secretion in association with pseudohypoparathyroidism.

Authors:  M S Shapiro; J Bernheim; A Gutman; I Arber; I M Spitz
Journal:  J Clin Endocrinol Metab       Date:  1980-09       Impact factor: 5.958

10.  Growth and development in a girl with pseudohypoparathyroidism and hypothyroidism. A longitudinal study.

Authors:  E M de Wijn; R Steendijk
Journal:  Acta Paediatr Scand       Date:  1982-07
View more
  6 in total

1.  A case of pseudohypoparathyroidism type la complicated with growth hormone deficiency: recovery of growth hormone secretion after vitamin D therapy.

Authors:  M Kaji; K Umeda; M Ashida; T Tajima
Journal:  Eur J Pediatr       Date:  2001-11       Impact factor: 3.183

2.  Familial growth hormone releasing factor deficiency in pseudopseudohypoparathyroidism.

Authors:  H F Stirling; D G Barr; C J Kelnar
Journal:  Arch Dis Child       Date:  1991-04       Impact factor: 3.791

3.  GH secretion in a cohort of children with pseudohypoparathyroidism type Ia.

Authors:  L de Sanctis; J Bellone; M Salerno; E Faleschini; M Caruso-Nicoletti; M Cicchetti; D Concolino; A Balsamo; F Buzi; L Ghizzoni; C de Sanctis
Journal:  J Endocrinol Invest       Date:  2007-02       Impact factor: 4.256

Review 4.  Albright's hereditary osteodystrophy.

Authors:  L C Wilson; R C Trembath
Journal:  J Med Genet       Date:  1994-10       Impact factor: 6.318

5.  Pseudohypoparathyroidism in a mother and son: phenotypic variability and associated disorder.

Authors:  M Ray; J Goraya; S Basu; S Mitra; B Poddar; V Parmar
Journal:  Indian J Pediatr       Date:  2001-03       Impact factor: 1.967

6.  Pseudopseudohypoparathyroidism associated with idiopathic growth hormone deficiency. Role of treatment with biosynthetic growth hormone.

Authors:  R Manfredi; A Zucchini; L Azzaroli; G Manfredi
Journal:  J Endocrinol Invest       Date:  1993-10       Impact factor: 4.256

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.